JPS58165742A - Nutritive composition for infant - Google Patents
Nutritive composition for infantInfo
- Publication number
- JPS58165742A JPS58165742A JP57046275A JP4627582A JPS58165742A JP S58165742 A JPS58165742 A JP S58165742A JP 57046275 A JP57046275 A JP 57046275A JP 4627582 A JP4627582 A JP 4627582A JP S58165742 A JPS58165742 A JP S58165742A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- infants
- nutritional composition
- casein
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Dairy Products (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
本発明は、消化吸収のきわめてすぐれた乳幼児用栄養組
成物に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a nutritional composition for infants that is highly digestible and absorbable.
更に詳却１には、本発明は、自然の牛乳蛋白とアミノ酸
を蛋白源とし、脂肪、炭水化物、ミネラル、ビタミン等
の栄養素を含有した乳幼児用栄養組成物に関するもので
ある。Further, in detail 1, the present invention relates to a nutritional composition for infants that uses natural milk protein and amino acids as protein sources and contains nutrients such as fats, carbohydrates, minerals, and vitamins.
不発明の目的の一つは、肝臓における尿素サイクル異常
を起こした乳幼児患者の治療栄養補給食として最適な蛋
白源を含有する栄養組成物を提供することにある。本発
明の他の目的は、栄養障害を起こした乳幼児用栄養組成
物を提供するととにある。One of the objects of the invention is to provide a nutritional composition containing a protein source that is suitable as a nutritional supplement for the treatment of infant patients with urea cycle abnormalities in the liver. Another object of the present invention is to provide a nutritional composition for malnourished infants.
一般に、乳幼児が尿素ザイクル異常を起とした時には血
中、髄液中のアンモニア値が高くなるのであるが、との
アンモニア値を低下させるには低蛋白食が必要になると
同時に必須アミノ酸は十分摂取させなければならない状
態となる。また、乳幼児が栄養障害を起こすと蛋白分解
能および吸収、利用性が低下するために必須アミノ酸の
摂取が不十分な状態と力るのである。Generally, when infants develop urea cycle abnormalities, ammonia levels in the blood and cerebrospinal fluid increase, but in order to lower ammonia levels, a low-protein diet is required, and at the same time, sufficient intake of essential amino acids is required. It becomes necessary to do so. Furthermore, when infants develop malnutrition, protein decomposition ability, absorption, and utilization decrease, leading to insufficient intake of essential amino acids.
、本発明は、このような乳幼児の機能障害に対処するだ
めの栄養組成物に関するもので、蛋白源としての全窒素
化合物重量基準で、下記組成から成る窒素化合物を蛋白
源として含有し、蛋白量の含有比を低下させたことを特
徴とする乳幼児用栄養組成物である。The present invention relates to a nutritional composition for dealing with such functional disorders in infants, which contains a nitrogen compound as a protein source having the following composition based on the weight of total nitrogen compounds as a protein source, and has a protein content of This is a nutritional composition for infants characterized by a reduced content ratio of.
カゼイン又はその塩ｃカゼイン蛋白として）２４〜３２
（重量％）
ホエーパウダー〔乳清蛋白として）
３０〜４０
Ｌ−イソロイシン ２．２〜３０
Ｌ−ロイシン ８．５〜１１．３Ｌ−メチオニ
ン ０６〜０４
Ｌ−シスチン ２．４〜ろ２Ｌ−フェニルア
ラニン ２．７〜３７Ｌ−チロシン ２
７〜６７
Ｌ−スレオニン ６０〜４．０Ｌ−）リゾトフ
ァン ０．５〜０．７Ｌ−バリン ４．０〜
５４
Ｌ−アルギ゛ニン ３，９〜５６Ｌ−ヒスチジン
１４〜２．０
本発明においては、単に蛋白摂取量を減少させるのでは
なく、消化吸収の良い自然蛋白とそれに加え、さらに必
要なアミノ酸を補強した形で全体の蛋白量を低下させる
ことに成功したものである。casein or its salt c casein protein) 24-32
(% by weight) Whey powder (as whey protein) 30-40 L-isoleucine 2.2-30 L-leucine 8.5-11.3 L-methionine 06-04 L-cystine 2.4-2L-phenylalanine 2 .7-37L-Tyrosine 2
7-67 L-threonine 60-4.0L-) Rizotophan 0.5-0.7L-valine 4.0-
54 L-Arginine 3,9-56 L-Histidine 14-2.0 In the present invention, rather than simply reducing protein intake, we supplement natural protein that is easily digestible and supplemented with necessary amino acids. In this way, we succeeded in reducing the total protein content.
アミノ酸のみで調製したものは、アミノ酸特有の異臭苦
味があり、飲みにくく、捷だ溶解時の滲透圧も高く乳幼
児にとって好ましいものではない。Products prepared only with amino acids have an off-flavor and bitter taste characteristic of amino acids, are difficult to swallow, and have a high osmotic pressure when dissolved, making them undesirable for infants.
本発明の栄養組成物は自然蛋白とアミノ酸を組み合わせ
ることによりきわめて飲みやすくなっており、更にこれ
とハチミツを少量添加することによって一層味がよくな
り、飲みやすくすることも可能である。The nutritional composition of the present invention is extremely easy to drink by combining natural proteins and amino acids, and can be further improved in taste and easier to drink by adding a small amount of honey.
また、本発明の栄養組成物は、経口投与および
１経管等の経腸的投与が可能である。Moreover, the nutritional composition of the present invention can be administered orally.
1. Enteral administration, such as through a tube, is possible.
本発明に使用するカゼインは、一般に塩の型で用いられ
るが、カゼインを溶解するための塩としては、ナトリウ
ム塩、カリウム塩、カルシウム塩等分散性、溶解性を良
くする各種の塩を使用することができる。The casein used in the present invention is generally used in the form of a salt, but various salts that improve dispersibility and solubility, such as sodium salt, potassium salt, and calcium salt, are used as the salt for dissolving casein. be able to.
ホエーパウダーとしては牛乳からカゼインを除去した後
の乳清部分から得ることができる。また更に脱塩したも
の、あるいは乳糖を除いたものなどの使用が可能である
。Whey powder can be obtained from the whey after casein has been removed from milk. Furthermore, it is possible to use products that have been further desalted or products from which lactose has been removed.
また、アミノ酸類は一般に遊離形で使用されるが、ヒス
チジンは塩酸塩でも使用できる。Furthermore, although amino acids are generally used in free form, histidine can also be used in hydrochloride form.
本発明の乳幼児用栄養組成物は、カゼイン、ホエーパウ
ダー、アミノ酸の必要組成を基本的成分とするものであ
るが、その他にも炭水化物、脂肪、ミネラル、ビタミン
などが適宜添加されるものである。炭水化物としては乳
糖と澱粉分解物、ハチミツ等のエネルギー源となるもの
を組み合わせて使用され、その使用量は４０〜６０重量
％である。The nutritional composition for infants of the present invention has the necessary composition of casein, whey powder, and amino acids as basic ingredients, but other carbohydrates, fats, minerals, vitamins, etc. may be added as appropriate. As carbohydrates, a combination of energy sources such as lactose, starch decomposition products, and honey is used, and the amount used is 40 to 60% by weight.
脂肪としては、例えばサフラワー油、パーム油、コーン
油、大豆油、ヤシ油等の植物性油、ラード等の動物性油
並びにＭＣＴ油（Ｍｉｄｉｕｍ −Ｃｈａｉｎ −Ｔｒ
ｉｇｌｙｃｅｒｉｄｅ）等が使用される。その使用量は
２０〜５０重量％である。Fats include, for example, vegetable oils such as safflower oil, palm oil, corn oil, soybean oil, and coconut oil, animal oils such as lard, and MCT oil (Midium-Chain-Tr).
iglyceride) etc. are used. The amount used is 20-50% by weight.
また、アミノ酸と脂肪の系を乳化させる為にシュガーエ
ステル、モノグリセリド、レシチン等の界面活性剤を添
加しておいて、使用時乳化、均質化が容易となるように
しておくのがよい。Further, in order to emulsify the amino acid and fat system, it is preferable to add a surfactant such as sugar ester, monoglyceride, lecithin, etc. to facilitate emulsification and homogenization during use.
ビタミンとしては、ＦＡＯ／ＷＨＯ合同食品規格計画Ｃ
ａｄ＠ｘ 食品規格委員会ＣＡＣ／Ｒ８７２−１９７６
乳児用調製乳の勧告国際規格（以下勧告規格という）を
満たせるようにビタミンＡｓ Ｂ１ｍ８２ ｓ Ｂ６
ｅ Ｂ１２＊ Ｃｏ Ｄ＠ Ｅ＠ Ｋｌ＠ パント
テン酸。As for vitamins, FAO/WHO Joint Food Standards Program C
ad@x Food Standards Commission CAC/R872-1976
In order to meet the Recommended International Standard for Infant Formula (hereinafter referred to as the Recommended Standard), vitamin As B1m82s B6
e B12* Co D@ E@ Kl@ Pantothenic acid.
ナイアシン、葉酸、ビオチン、イノジット、コリン（レ
シチンτ′代用することもできる）等が使用される。ビ
タミン類全体の使用量は０．１重量饅程度で十分である
。Niacin, folic acid, biotin, inosit, choline (which can also be substituted for lecithin τ'), etc. are used. The total amount of vitamins used is about 0.1 weight of rice cake.
ミネラルとしては、勧告規格を満たせるように、硫酸第
一鉄、コハク酸クエン酸鉄ナトリウム等の鉄塩、硫酸銅
、グルコン酸銅等の銅塩、硫酸亜鉛。Minerals include ferrous sulfate, iron salts such as sodium iron citrate succinate, copper salts such as copper sulfate and copper gluconate, and zinc sulfate in order to meet the recommended standards.
塩化亜鉛等の亜鉛塩、酢酸マンガン等のマンガン塩、酢
酸コバルト等のコバルト塩、ヨウ化カリウム、炭酸カリ
ウム等のカリウム塩およびヨウ化物、塩化マグネシウム
等のマグネシウム塩、クエン酸三ナトリウム、塩化ナト
リウム等のナトリウム塩、グリセロリン酸カルシウム、
炭酸カルシウム、塩化カルシウム等のカルシウム塩およ
びリン酸塩、リン酸−カリウム、リン酸二カリウム等の
リン酸塩およびカリウム塩が使用される。ミネラル全体
の使用量は２〜３重量％程変である。Zinc salts such as zinc chloride, manganese salts such as manganese acetate, cobalt salts such as cobalt acetate, potassium salts and iodides such as potassium iodide and potassium carbonate, magnesium salts such as magnesium chloride, trisodium citrate, sodium chloride, etc. sodium salt, calcium glycerophosphate,
Calcium salts such as calcium carbonate, calcium chloride and phosphates and potassium salts such as phosphate, potassium phosphate, dipotassium phosphate are used. The total amount of minerals used varies by about 2-3% by weight.
以上の各種組成物は均一に混合し、粉末状に調製され乳
幼児用栄養組成物とされる。The above various compositions are mixed uniformly and prepared into a powder form to form a nutritional composition for infants.
本発明の乳幼児用栄養組成物は粉末状に混合調整されて
いるので、投与時には標準で１５％Ｗ／Ｖの濃度に水に
溶解させて投与される。投与は経口投与、経腸投与のい
ずれでもよい。Since the nutritional composition for infants of the present invention is mixed and prepared in powder form, it is administered after being dissolved in water to a standard concentration of 15% W/V. Administration may be either oral or enteral administration.
本発明の乳幼児用栄養組成物を尿素サイクル異常患者に
投与することによって乳幼児の血中、髄液中のアンモニ
アｌｉｔを低下せしめることができ、さらに栄養補給が
可能となる。By administering the nutritional composition for infants of the present invention to patients with urea cycle abnormalities, ammonia lit in the infant's blood and cerebrospinal fluid can be lowered, and nutritional supplementation becomes possible.
また、本発明の乳幼児用栄養組成物は例えば腎不全の場
合のようにたん白質摂取制限の厳しい場合でも少量のた
ん白質摂取で必須アミノ酸をバランス良く摂取すること
が可能であるだめに、広く栄養障害を起こした乳幼児に
投与することができるものである。In addition, the nutritional composition for infants of the present invention can be widely used as a nutritional supplement since it is possible to ingest essential amino acids in a well-balanced manner with a small amount of protein intake even in cases where protein intake is severely restricted, such as in cases of renal failure. It can be administered to infants and children who have developed the disorder.
矢に本発明の実施例を示す。The arrows indicate examples of the present invention.
実施例１゜ 次に示す物質を均一に混合調製した。Example 1゜ The following substances were uniformly mixed and prepared.
カゼインナトリウム ２．２４５？
ホエーパウダー ３．０３１ｙ−Ｌ−イソロイシ
ン ０．１５７ｙ−Ｌ−ロイシン ０．５
８２ｙ−Ｌ−メチオニン ００１６ノ
Ｌ−シスチン ０１６５．ｆ−Ｌ−フェニル
アラニン ０．１８９？Ｌ−チロシン ０
．２０７？
Ｌ−スレオニン ０．２５０ノ
Ｌ−）リプトファン ００３７ノ
Ｌ−バリン ０．２７５！１Ｉ−ｊＬ−アル
ギニン 、０．２７６！？Ｌ−ヒスチジン塩酸塩
０．１３６ｉ！−ＭＣ’Ｔ油 １６．６
６０？植物性油 ２７．５６８？乳糖
５３．５４０！？ハチミツ
３．２７０？ニコチン酸アミド ６．０ｍ９
ビタミンＢ２ ［１，９１ｍ２ビタミン
Ｂ−１ｉ ７．９μｇイノジット
１２．４９■ビオチン ｏ０６
ｍｇ
ｄｌ −ａ −） コフｘｏ−ル６．（３ｒｒｕ２ビタ
ミンＡとビタミンＤの混合物６．７１１１ｎ９ビタミン
Ｋｌ １１４μｇ塩酸チアミン（ｖ、Ｂ
１）ｏ、７２■
塩酸ピリドキシ７（Ｖ、 Ｂ６ ） ０．４３１９
アスコルビン酸（Ｖ、Ｃ） ５４、ｏ１ｎ９葉酸
０２４〜
パントテン酸カルシウム ２．４０７％１コハク
酸クエン酸鉄ナトリウム８０．０■ヨウ化カリウム
０．１１■
グリセロリン酸カルシウム ４２１３η炭酸カルシウ
ム ５６５．１３ｍ９水酸化カルシウム
４１．４ｍｇ塩化カルシウムニ水塩 ６３．ｏ■
リン酸−カリウム １０８．３即リン酸二カリウ
ム ２３１．５１ｎ９塩化マグネシウム六水塩
２９４．０ ｍｙ塩化ナトリウム ２ Ｄ
７．９即クエン酸三ナトリウムニ水塩 ４４．１ｍｇ
粉末レシチン ９０．０■
シユガーエステル ２２５．０ｍ９モノグリセリド
１１４．０〜
硫酸銅五水塩 １．５５２■塩化亜鉛
５．１６■酢酸マンガン四水塩
０．６６９〜酢酸コバルト四水塩 ０．２１
１ｍ９得られた乳幼児用栄養組成物は、１５％Ｗ／Ｖで
４０℃の水に溶解し、経口的又は経腸的に乳幼児に投与
される。Sodium caseinate 2.245? Whey powder 3.031y-L-isoleucine 0.157y-L-leucine 0.5
82y-L-methionine 0016-L-cystine 0165. f-L-phenylalanine 0.189? L-tyrosine 0
．． 207? L-threonine 0.250L-)Liptophan 0037L-valine 0.275!1I-jL-arginine, 0.276! ? L-histidine hydrochloride
0.136i! -MC'T oil 16.6
60? Vegetable oil 27.568? lactose
53.540! ? honey
3.270? Nicotinamide 6.0m9 Vitamin B2 [1,91m2 Vitamin B-1i 7.9μg Inosit
12.49 ■ Biotin o06
mg dl-a-) Coffoxol6. (3rru2 Mixture of vitamin A and vitamin D6.7111n9 Vitamin Kl 114μg Thiamine hydrochloride (v, B
1) o, 72■ Pyridoxy hydrochloride 7 (V, B6) 0.4319
Ascorbic acid (V, C) 54, o1n9 folic acid
024~ Calcium pantothenate 2.407% Sodium iron citrate 1-succinate 80.0 ■ Potassium iodide
0.11■ Calcium glycerophosphate 4213η Calcium carbonate 565.13m9 Calcium hydroxide
41.4mg Calcium chloride dihydrate 63. o ■
Potassium phosphate 108.3 Instant dipotassium phosphate 231.51n9 Magnesium chloride hexahydrate
294.0 my Sodium Chloride 2 D
7.9 Instant trisodium citrate dihydrate 44.1mg
Powdered lecithin 90.0■ Shugar ester 225.0m9 Monoglyceride 114.0~ Copper sulfate pentahydrate 1.552■ Zinc chloride
5.16 ■ Manganese acetate tetrahydrate
0.669 ~ Cobalt acetate tetrahydrate 0.21
1 m9 of the obtained nutritional composition for infants is dissolved in water at 40° C. at 15% W/V and administered to infants orally or enterally.
代理人 弁理士 戸 １）親 男Agent Patent Attorney 1) Parent Male
Claims (1)
成る音素化合物を蛋白源として含有し、蛋白量の含有比
を低下させたことを特徴とする乳幼児用栄養組成物。 カゼイン又はその塩（カゼイン蛋白として）２４〜３２
〔重量％） ホエーパウダー（乳清蛋白として） ３０〜４０ Ｌニイソロイシン ２．２〜３．ＯＬ−ロイシン
８．５〜１１．６Ｌ−メチオニン ０！
１〜０，４Ｌ−シスチン ２，４〜３２Ｌ−
フェニルアラニン ２．７〜３．７Ｌ−チロシン
２．７〜３．７し一スレオニン ６０〜
４．０ Ｔ、 −）リゾトファン ０５〜０．７Ｌ−バリン
４０〜５．４ Ｌ−アルギニン ３９〜５３ Ｌ−ヒスチジン １．４〜２０[Scope of Claims] A nutritional composition for infants, characterized in that it contains a phonetic compound having the following composition as a protein source, based on the weight of total nitrogen compounds as a protein source, and has a reduced protein content ratio. Casein or its salt (as casein protein) 24-32
[Weight %] Whey powder (as whey protein) 30-40 L diisoleucine 2.2-3. OL-leucine
8.5-11.6L-Methionine 0!
1-0,4L-cystine 2,4-32L-
Phenylalanine 2.7-3.7L-Tyrosine
2.7-3.7 Threonine 60-
4.0 T, -) lysotophan 05-0.7 L-valine
40-5.4 L-arginine 39-53 L-histidine 1.4-20
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57046275A JPS58165742A (en) | 1982-03-25 | 1982-03-25 | Nutritive composition for infant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57046275A JPS58165742A (en) | 1982-03-25 | 1982-03-25 | Nutritive composition for infant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58165742A true JPS58165742A (en) | 1983-09-30 |
| JPH0335896B2 JPH0335896B2 (en) | 1991-05-29 |
Family
ID=12742668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57046275A Granted JPS58165742A (en) | 1982-03-25 | 1982-03-25 | Nutritive composition for infant |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58165742A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5186963A (en) * | 1992-01-07 | 1993-02-16 | Karen Howman | Therapeutic dietary composition containing amaranth |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| US5550146A (en) * | 1992-12-23 | 1996-08-27 | Abbott Laboratories | Medical foods for the nutritional support of infant/toddler metabolic diseases |
| US5670201A (en) * | 1991-06-21 | 1997-09-23 | Snow Brand Milk Co., Ltd. | Low allergenic nutrient composition and method of using same |
| WO2001022837A1 (en) * | 1999-09-29 | 2001-04-05 | Societe Des Produits Nestle S.A. | Composition comprising casein protein and whey protein |
| US6506422B1 (en) * | 1996-08-30 | 2003-01-14 | Nestec S.A. | Nutritional formula for phenylketonuria patients |
| JP2004262848A (en) * | 2003-03-03 | 2004-09-24 | Ryoshoku Kenkyukai | Active oxygen-diminishing composition |
| JP2019030269A (en) * | 2017-08-09 | 2019-02-28 | 京都府公立大学法人 | Engineering method of protein composition with reduced protein metabolism requirement, and manufacturing method of protein-containing food and drink composition based on the engineering method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861658A (en) * | 1971-11-15 | 1973-08-29 | ||
| JPS5668374A (en) * | 1979-11-08 | 1981-06-09 | Jun Sawada | Food composition for hepatic insufficiency |
| JPS5711910A (en) * | 1980-06-25 | 1982-01-21 | Otsuka Shokuhin Kogyo Kk | Intestinal preparation of nutrition supplement |
-
1982
- 1982-03-25 JP JP57046275A patent/JPS58165742A/en active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861658A (en) * | 1971-11-15 | 1973-08-29 | ||
| JPS5668374A (en) * | 1979-11-08 | 1981-06-09 | Jun Sawada | Food composition for hepatic insufficiency |
| JPS5711910A (en) * | 1980-06-25 | 1982-01-21 | Otsuka Shokuhin Kogyo Kk | Intestinal preparation of nutrition supplement |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670201A (en) * | 1991-06-21 | 1997-09-23 | Snow Brand Milk Co., Ltd. | Low allergenic nutrient composition and method of using same |
| US5186963A (en) * | 1992-01-07 | 1993-02-16 | Karen Howman | Therapeutic dietary composition containing amaranth |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| US5550146A (en) * | 1992-12-23 | 1996-08-27 | Abbott Laboratories | Medical foods for the nutritional support of infant/toddler metabolic diseases |
| US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
| US6506422B1 (en) * | 1996-08-30 | 2003-01-14 | Nestec S.A. | Nutritional formula for phenylketonuria patients |
| WO2001022837A1 (en) * | 1999-09-29 | 2001-04-05 | Societe Des Produits Nestle S.A. | Composition comprising casein protein and whey protein |
| JP2003510059A (en) * | 1999-09-29 | 2003-03-18 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | Composition comprising casein protein and whey protein |
| US7776332B1 (en) * | 1999-09-29 | 2010-08-17 | Nestec S.A. | Composition comprising casein protein and whey protein |
| JP2004262848A (en) * | 2003-03-03 | 2004-09-24 | Ryoshoku Kenkyukai | Active oxygen-diminishing composition |
| JP2019030269A (en) * | 2017-08-09 | 2019-02-28 | 京都府公立大学法人 | Engineering method of protein composition with reduced protein metabolism requirement, and manufacturing method of protein-containing food and drink composition based on the engineering method |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0335896B2 (en) | 1991-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4368204A (en) | Nutrition composition for pediatrics | |
| US3697287A (en) | Amino acid food composition | |
| US5719133A (en) | Adolescent dietary composition | |
| US5108767A (en) | Liquid nutritional product for persons receiving renal dialysis | |
| US6667063B2 (en) | Nutritional or therapeutic supplement and method | |
| JPH0322366B2 (en) | ||
| US3701666A (en) | Process for making amino acid composition | |
| AU2009306497B2 (en) | Nutritional composition with anti-regurgitation properties | |
| WO2013174306A1 (en) | Infant formula milk powder and preparation method thereof | |
| EP2081450A1 (en) | Long-term feed - cancer patient | |
| JP2014501530A (en) | Nutritional supplements containing calcium beta-hydroxy-betamethylbutyrate and conjugated linoleic acid | |
| JPH10174565A (en) | Iron-calcium mineral supplementary substance having high bioavailability | |
| WO1993006834A1 (en) | Enteral preparation for cancer therapy | |
| JP2002065212A (en) | Food composition for strengthening muscle, and muscle- strengthening agent | |
| JPS58165742A (en) | Nutritive composition for infant | |
| MXPA06001706A (en) | Multivitamin syrup for children or young adults. | |
| TW201507627A (en) | Nutritional composition comprising whey and hydrolyzed casein and uses thereof | |
| Abras et al. | Nitrogen utilization in uremic patients fed by continuous nasogastric infusion | |
| PT1474003E (en) | Human milk supplement | |
| JP6313042B2 (en) | Fluid nutrition composition containing L-arginine and method for producing the same | |
| JPS595111A (en) | Nutritional preparation for infants with phenylketonuria | |
| JPS58216122A (en) | Histidinemic infant nutritional preparation | |
| JP3589807B2 (en) | Nutritional composition of liquid preparation adapted to each symptom of kidney disease patients | |
| US20060147495A1 (en) | Amino acid-based nutritional formulation | |
| JPS58180429A (en) | Nutritional preparations for infants with homocystinuria |